Mechanism
IL-31RA x OX40L
Assets acting on this target.
- Class
- bispecific antibody (anti-IL-31RA x anti-OX40L; Sunshine Guojian Pharmaceutical)
- Pathway
- dual blockade of IL-31 itch/pruritus signaling and OX40L T-cell costimulation
Research
Sign in to access ResearchExplore this mechanism at different depths
Research adds deeper and simplified explanation variants while preserving the same scientific register and source caveats.
0 of 0 assets
No assets match these filters.